Quantinuum Inc. Class A Common Stock
QNT
$63.59
-7.18%
Quantinuum Inc. is a full-stack quantum technology company providing hardware, software, and developer tools to scale quantum computing and develop applications. As a leader in the emerging quantum computing industry, it distinguishes itself through its integrated approach, combining advanced quantum systems like Helios with software platforms such as Quantum Origin and Nexus. The current investor narrative centers on the company's recent IPO in June 2026, its potential to capitalize on the growing quantum computing market, and its connection to Honeywell's spinoff, which has drawn attention to its long-term growth prospects despite current losses and high volatility.…
QNT
Quantinuum Inc. Class A Common Stock
$63.59
Related headlines
Investment Opinion: Should I buy QNT Today?
Based on the analysis, I rate Quantinuum as a Hold. The company has significant long-term potential in the quantum computing space, but the current financial performance is weak, and the valuation is extremely high. The average analyst target of $98.75 implies a 77.5% upside, but this is contingent on a successful turnaround in revenue growth. Given the high uncertainty and speculative nature, a Hold rating is appropriate until clearer signs of revenue stabilization emerge.
Sign up to view all
QNT 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The company has strong long-term potential in quantum computing, but the current financial performance is poor, and the valuation is stretched. The key factor is whether revenue can recover as analysts expect. If revenue growth resumes and the company shows a path to profitability, the stock could rally significantly. However, if the decline continues, the stock will likely fall further. I would upgrade to bullish if revenue growth exceeds 20% YoY in the next quarter and the PS ratio drops below 30x. I would downgrade to bearish if revenue continues to decline and the company faces liquidity issues.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Quantinuum Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $97.17 and implied upside of +52.8% versus the current price.
Average Target
$97.17
0 analysts
Implied Upside
+52.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$78 - $155
Analyst target range
Quantinuum has coverage from 12 analysts, with a consensus recommendation of 'none' (likely meaning a hold or neutral stance). The average target price is $98.75, implying an upside of 77.5% from the current price of $55.65. The target range spans from $78.00 to $155.00, with the low target still representing a 40.2% upside, suggesting that even the most bearish analyst sees significant value. The wide spread between low and high targets (77.0 points) indicates high uncertainty, likely due to the company's early stage and volatile revenue. The high target of $155.00 assumes successful execution of its quantum technology roadmap and market adoption, while the low target of $78.00 prices in potential delays or competitive pressures. The lack of a clear consensus recommendation and the wide target range highlight the speculative nature of this investment, with limited institutional coverage typical of a newly listed small-cap stock.
Bulls vs Bears: QNT Investment Factors
Quantinuum presents a classic high-risk, high-reward investment case. On the bullish side, the company has a strong balance sheet, high gross margins, and significant upside per analyst targets. However, the bear case is compelling due to the 72.5% revenue collapse, extreme valuation multiples, and negative operating margins. Currently, the bearish evidence is stronger because the revenue decline is severe and the valuation leaves no room for error. The most important tension is whether the revenue drop is a temporary transition issue or a fundamental business problem. If revenue recovers as analysts expect, the stock could soar; if not, the high valuation will compress, leading to further downside.
Bullish
- High Gross Margin at 65.1%: Despite the revenue decline, Quantinuum maintains a gross margin of 65.1%, indicating strong pricing power and a scalable business model. This suggests that as revenue grows, the company could achieve profitability more easily than competitors with lower margins.
- Analyst Targets Imply 77.5% Upside: The average analyst target price is $98.75, representing a 77.5% upside from the current price of $55.65. Even the lowest analyst target of $78.00 implies a 40.2% upside, suggesting that analysts see significant value despite recent volatility.
- Strong Balance Sheet with Low Debt: Quantinuum has a debt-to-equity ratio of 0.0062 and a current ratio of 14.25, indicating minimal leverage and ample liquidity. This financial stability provides a cushion for continued investment in R&D and operations without the risk of insolvency.
- Strategic Position in Quantum Computing: As a full-stack quantum computing company, Quantinuum is well-positioned in a nascent industry with massive long-term potential. Its integration of hardware and software, including Helios and Quantum Origin, creates a competitive moat that could drive future revenue growth.
Bearish
- Revenue Collapse of 72.5% YoY: Q1 2026 revenue was $5.24 million, down from $19.09 million in Q1 2025, a 72.5% decline. This dramatic contraction raises serious concerns about the company's ability to generate sustainable revenue, possibly due to the Honeywell spinoff or a shift in business model.
- Extremely High Valuation (PS 64.8): The trailing price-to-sales ratio is 64.83, and even the forward PS is around 44.6 based on estimated revenue of $44.95 million. This implies the market is pricing in aggressive growth that may not materialize, leaving little room for error.
- Negative Operating Margin of -1713.7%: The operating margin is -1713.7% (operating income of -$137.7 million on revenue of $5.24 million), indicating that the company is spending far more than it earns. This cash burn is unsustainable without significant revenue growth or additional funding.
- High Volatility and Recent Downtrend: The stock has fallen 25.4% in the past month and is down 43.1% from its 52-week high of $86.79. This volatility and downward momentum suggest that the market is uncertain about the company's near-term prospects.
QNT Technical Analysis
Quantinuum's stock has exhibited a volatile trading pattern since its IPO on June 4, 2026. Over the past year, the price has increased by 4.24%, but this masks significant swings; the current price of $55.65 is near the lower end of its 52-week range, sitting at approximately 64% of the range (calculated as (55.65 - 47.06) / (86.79 - 47.06) * 100). This positioning near the lows suggests a potential value opportunity, but also reflects a sharp decline from its highs, indicating a falling knife scenario that warrants caution.
Beta
—
—
Max Drawdown
-43.1%
Largest decline past year
52-Week Range
$47-$87
Price range past year
Annual Return
—
Cumulative gain past year
| Period | QNT Return | S&P 500 |
|---|---|---|
| 1m | +5.1% | +2.9% |
| 3m | — | +5.0% |
| 6m | — | +13.9% |
| 1y | — | +20.4% |
| ytd | — | +13.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QNT Fundamental Analysis
Quantinuum's revenue trajectory is concerning, with Q1 2026 revenue of $5.24 million, a dramatic decline from $19.09 million in Q1 2025, representing a 72.5% year-over-year drop. This sharp contraction suggests a fundamental business challenge, possibly due to the transition from Honeywell's structure or a shift in revenue recognition. The company's gross margin remains high at 65.1%, but the revenue decline is severe, and the multi-quarter trend shows no signs of stabilization, raising questions about the sustainability of its growth narrative.
Quarterly Revenue
$5237000.0B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
65.1%
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QNT Overvalued?
Given that Quantinuum has negative net income (EPS of -0.48 in Q1 2026), the price-to-sales (PS) ratio is the most appropriate valuation metric. The trailing PS ratio is 64.83, while the forward PS ratio is not directly provided but can be estimated using estimated revenue of $44.95 million, implying a forward PS of approximately 44.6 (market cap of $2.0 billion divided by $44.95 million). The gap between trailing and forward PS suggests the market expects revenue to recover, but the absolute levels are extremely high, indicating aggressive growth expectations.
PE
-28.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-2.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company's revenue has collapsed by 72.5% year-over-year, from $19.09 million to $5.24 million, indicating a potential loss of market traction or a transition issue. Operating losses are massive, with an operating margin of -1713.7%, and the company burned through $137.7 million in operating cash flow in Q1 2026 alone. While the balance sheet is strong with a current ratio of 14.25 and minimal debt, the cash burn rate is unsustainable without substantial revenue growth or additional capital raises, which could dilute shareholders. The negative EPS of -0.48 and net margin of -231.3% highlight the lack of profitability and the dependence on external funding.
FAQ
The key risks include: (1) Financial risk: Revenue decline of 72.5% and negative operating margins of -1713.7%, leading to cash burn. (2) Valuation risk: High PS ratio of 64.83 could compress if growth expectations are not met. (3) Competitive risk: The quantum computing industry is competitive, with players like Rigetti and D-Wave also receiving funding. (4) Company-specific risk: The Honeywell spinoff may cause operational disruptions. The most severe risk is the revenue decline continuing, which could lead to a stock price drop to the 52-week low of $47.06.
The 12-month forecast is uncertain, with three scenarios: Bull case (30% probability) targets $120-$155, base case (45% probability) targets $80-$100, and bear case (25% probability) targets $47-$60. The base case is most likely, assuming revenue recovers to around $45 million and the stock reaches the average analyst target of $98.75. The key assumption is that the revenue decline is temporary and the company can achieve growth. If revenue fails to recover, the stock could fall to the bear case.
QNT is overvalued based on current financials, with a trailing PS ratio of 64.83 and a forward PS of 44.6. These multiples are extremely high compared to typical tech companies, indicating that the market is pricing in aggressive growth. However, if the company achieves the estimated revenue of $44.95 million, the forward PS would be more reasonable, though still elevated. The stock is trading at a premium to its historical valuation, but the potential for growth could justify the premium if the company executes well.
QNT is a high-risk, high-reward stock. The average analyst target of $98.75 implies a 77.5% upside, but the company's revenue has declined 72.5% YoY, and the valuation is extremely high with a PS ratio of 64.83. For investors with a high risk tolerance and a long-term horizon, it could be a good buy if they believe in the quantum computing story. However, for conservative investors, the risks are too great. It is a good buy only if you are prepared for significant volatility and have a strong conviction in the company's technology and growth potential.
QNT is more suitable for long-term investment due to its high volatility and speculative nature. The stock has a beta that is not provided, but its 25.4% decline in the past month indicates high volatility. The company is in the early stages of a potentially transformative industry, and long-term investors could benefit from the growth of quantum computing. However, short-term trading is risky due to the wide price swings and uncertainty. A minimum holding period of 3-5 years is recommended to allow the technology to mature and the company to achieve profitability.